The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Suppression of induced pluripotent stem cell generation by the p53–p21 pathway
Open accessAbstract
Induced pluripotent stem (iPS) cells can be generated from somatic cells by the introduction of Oct3/4 (also known as Pou5f1), Sox2, Klf4 and c-Myc, in mouse and in human. The efficiency of this process, however, is low. Pluripotency can be induced without c-Myc, but with even lower efficiency. A p53 (also known as TP53 in humans and Trp53 in mice) short-interfering RNA (siRNA) was recently shown to promote human iPS cell generation, but the specificity and mechanisms remain to be determined. Here we report that up to 10% of transduced mouse embryonic fibroblasts lacking p53 became iPS cells, even without the Myc retrovirus. The p53 deletion also promoted the induction of integration-free mouse iPS cells with plasmid transfection. Furthermore, in the p53-null background, iPS cells were generated from terminally differentiated T lymphocytes. The suppression of p53 also increased the efficiency of human iPS cell generation. DNA microarray analyses identified 34 p53-regulated genes that are common in mouse and human fibroblasts. Functional analyses of these genes demonstrate that the p53-p21 pathway serves as a barrier not only in tumorigenicity, but also in iPS cell generation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is known that OSKM induction activates the p53–p21 pathway25.”
From In vivo partial reprogramming of myofibers promotes muscle regeneration by remodeling the stem cell niche (2021) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Self-citationInduction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Self-citationInduced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Generation of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,438
Self-citationIn vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state
Wernig, M., Meissner, A., Foreman, R. K., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein, B., & Jaenisch, R. (2007) · Nature · doi:10.1038/nature05944 · Cited by 2,732
Reprogramming of human somatic cells to pluripotency with defined factors
Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 2,436
Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts
Nakagawa, M., Koyanagi, M., Tanabe, K., Takahashi, K., Ichisaka, T., Aoi, T., Okita, K., Mochiduki, Y., Takizawa, N., & Yamanaka, S. (2008) · Nature Biotechnology · doi:10.1038/nbt1374 · Cited by 2,380
Self-citationGeneration of Mouse Induced Pluripotent Stem Cells Without Viral Vectors
Okita, K., Nakagawa, M., Hong, H., Ichisaka, T., & Yamanaka, S. (2008) · Science · doi:10.1126/science.1164270 · Cited by 2,056
Self-citationMaherali, N., Sridharan, R., Xie, W., Utikal, J., Eminli, S., Arnold, K., Stadtfeld, M., Yachechko, R., Tchieu, J., Jaenisch, R., et al. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.05.014 · Cited by 1,725
Plat-E: an efficient and stable system for transient packaging of retroviruses
MORITA, S., Kojima, T., & Kitamura, T. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301206 · Cited by 1,660
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 1,003
Induced Neuronal Cells: How to Make and Define a Neuron
Yang, N., Ng, Y. H., Pang, Z. P., Südhof, T. C., & Wernig, M. (2011) · Cell stem cell · doi:10.1016/j.stem.2011.11.015 · Cited by 185
Lessons from human teratomas to guide development of safe stem cell therapies
Cunningham, J. J., Ulbright, T. M., Pera, M. F., & Looijenga, L. H. J. (2012) · Nature Biotechnology · doi:10.1038/nbt.2329 · Cited by 180
Molecular classification of prostate cancer using curated expression signatures
Markert, E. K., Mizuno, H., Vázquez, A., & Levine, A. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117029108 · Cited by 182
Zunder, E. R., Lujan, E., Goltsev, Y., Wernig, M., & Nolan, G. P. (2015) · Cell stem cell · doi:10.1016/j.stem.2015.01.015 · Cited by 180
Present and future challenges of induced pluripotent stem cells
Ohnuki, M., & Takahashi, K. (2015) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2014.0367 · Cited by 182
Self-citationDNA Damage Responses in Human Induced Pluripotent Stem Cells and Embryonic Stem Cells
Momčilović, O., Knobloch, L., Fornsaglio, J. L., Varum, S., Easley, C. A., & Schatten, G. P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013410 · Cited by 182
iPS cells: A source of cardiac regeneration
Yoshida, Y., & Yamanaka, S. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.10.026 · Cited by 178
Self-citationAging and reprogramming: a two-way street
Mahmoudi, S., & Brunet, A. (2012) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2012.10.004 · Cited by 171
Targeting cancer stem cells: emerging role of Nanog transcription factor
Wu, C., Wang, M., & Chiou, S.-H. (2013) · OncoTargets and Therapy · doi:10.2147/ott.s38114 · Cited by 174
Yoshida, Y., & Yamanaka, S. (2010) · Circulation · doi:10.1161/circulationaha.109.881433 · Cited by 176
Self-citationCis- and trans-acting lncRNAs in pluripotency and reprogramming
Yan, P., Luo, S., Lu, J., & Shen, X. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2017.07.009 · Cited by 173
Direct Reprogramming of Murine Fibroblasts to Hematopoietic Progenitor Cells
Batta, K., Florkowska, M., Kouskoff, V., & Lacaud, G. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.11.002 · Cited by 169
Nonstochastic Reprogramming from a Privileged Somatic Cell State
Guo, S., Zi, X., Schulz, V., Cheng, J., Zhong, M., Koochaki, S., Megyola, C. M., Pan, X., Heydari, K., Weissman, S. M., et al. (2014) · Cell · doi:10.1016/j.cell.2014.01.020 · Cited by 174
p53 loss promotes acute myeloid leukemia by enabling aberrant self-renewalPreprint
Zhao, Z., Zuber, J. A., Díaz-Flores, E., Lintault, L., Kogan, S. C., Shannon, K., & Lowe, S. W. (2010) · Genes & Development · doi:10.1101/gad.1940710 · Cited by 175
Gingival Fibroblasts as a Promising Source of Induced Pluripotent Stem Cells
Egusa, H., Okita, K., Kayashima, H., Yu, G., Fukuyasu, S., Saeki, M., Matsumoto, T., Yamanaka, S., & Yatani, H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012743 · Cited by 169
Self-citationChen, X., Sun, K., Jiao, S., Cai, N., Zhao, X., Zou, H., Xie, Y., Wang, Z., Zhong, M., & Wei, L. (2014) · Scientific Reports · doi:10.1038/srep07481 · Cited by 167
Derivation of Induced Pluripotent Stem Cells from Human Peripheral Blood T Lymphocytes
Brown, M. E., Rondon, E., Rajesh, D., Mack, A. A., Lewis, R. L., Feng, X., Zitur, L. J., Learish, R. D., & Nuwaysir, E. F. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011373 · Cited by 167
Liang, G., He, J., & Zhang, Y. (2012) · Nature Cell Biology · doi:10.1038/ncb2483 · Cited by 166
Wang, Q., Zou, Y., Nowotschin, S., Kim, S. Y., Li, Q. V., Soh, C.-L., Su, J., Zhang, C., Shu, W., Xi, Q., et al. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.10.002 · Cited by 166
Gain-of-Function Mutant p53: All the Roads Lead to Tumorigenesis
Stein, Y., Rotter, V., & Aloni-Grinstein, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246197 · Cited by 169
Inactivation of p53 in breast cancers correlates with stem cell transcriptional signatures
Mizuno, H., Spike, B. T., Wahl, G. M., & Levine, A. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017001108 · Cited by 161
Mehta, S. V., Huillard, E., Kesari, S., Maire, C. L., Golebiowski, D., Harrington, E. P., Alberta, J. A., Kane, M., Theisen, M., Ligon, K. L., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.01.035 · Cited by 165
Seki, T., Yuasa, S., & Fukuda, K. (2012) · Nature Protocols · doi:10.1038/nprot.2012.015 · Cited by 162
p53 is balancing development, differentiation and de-differentiation to assure cancer prevention
Molchadsky, A., Rivlin, N., Brosh, R., Rotter, V., & Sarig, R. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq101 · Cited by 161
Ubiquitin‐specific proteases 7 and 11 modulate Polycomb regulation of the INK4a tumour suppressor
Maertens, G. N., Messaoudi, S. E., Elderkin, S., Hiom, K. J., & Peters, G. G. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.129 · Cited by 162
Sarig, R., Rivlin, N., Brosh, R., Bornstein, C., Kamer, I., Ezra, O., Molchadsky, A., Goldfinger, N., Brenner, O. J., & Rotter, V. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20100797 · Cited by 162
Feeder-Free Derivation of Human Induced Pluripotent Stem Cells with Messenger RNA
Warren, L., Ni, Y., Wang, J., & Guo, X. (2012) · Scientific Reports · doi:10.1038/srep00657 · Cited by 154
Deficiency of microRNA miR-34a expands cell fate potential in pluripotent stem cells
Choi, Y. J., Lin, C., Risso, D., Chen, S., Kim, T. A., Tan, M. H., Li, J. B., Wu, Y., Chen, C., Xuan, Z., et al. (2017) · Science · doi:10.1126/science.aag1927 · Cited by 158
Hallmarks of progeroid syndromes: lessons from mice and reprogrammed cells
Carrero, D., Soria-Valles, C., & López-Otín, C. (2016) · Disease Models & Mechanisms · doi:10.1242/dmm.024711 · Cited by 153
p27Kip1 Directly Represses Sox2 during Embryonic Stem Cell Differentiation
Li, H., Collado, M., Villasante, A., Matheu, A., Lynch, C. J., Cañamero, M., Rizzoti, K., Carneiro, C., Martínez, G., Vidal, A., et al. (2012) · Cell stem cell · doi:10.1016/j.stem.2012.09.014 · Cited by 157
The p53 family and the hypoxia-inducible factors (HIFs): determinants of cancer progression
Amelio, I., & Melino, G. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.04.007 · Cited by 152
p53, Stem Cells, and Reprogramming: Tumor Suppression beyond Guarding the Genome
Spike, B. T., & Wahl, G. M. (2011) · Genes & Cancer · doi:10.1177/1947601911410224 · Cited by 160
Woo, H. G., Wang, X. W., Budhu, A., Kim, Y. H., Kwon, S. M., Tang, Z., Sun, Z., Harris, C. C., & Thorgeirsson, S. S. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.11.034 · Cited by 158
Zhao, W., Li, Q., Ayers, S. D., Gu, Y., Shi, Z. Q., Zhu, Q., Chen, Y., Wang, H. Y., & Wang, R. (2013) · Cell · doi:10.1016/j.cell.2013.02.006 · Cited by 153
Serum Starvation Induced Cell Cycle Synchronization Facilitates Human Somatic Cells Reprogramming
Chen, M., Huang, J., Yang, X., Liu, B., Zhang, W., Huang, L., Deng, F., Ma, J., Bai, Y., Lu, R., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0028203 · Cited by 159
The oncogene c-Jun impedes somatic cell reprogramming
Liu, J., Han, Q., Peng, T., Peng, M., Wei, B., Li, D., Wang, X., Yu, S., Yang, J., Cao, S., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3193 · Cited by 146
Genomic instability in induced stem cells
Pasi, C. E., Dereli-Oz, A., Negrini, S., Friedli, M., Fragola, G., Lombardo, A., Houwe, G. V., Naldini, L., Casola, S. S., Testa, G., et al. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.9 · Cited by 147
Jiang, J., Lv, W., Ye, X., Wang, L., Zhang, M., Yang, H., Okuka, M., Zhou, C., Zhang, X., Liu, L., et al. (2012) · Cell Research · doi:10.1038/cr.2012.157 · Cited by 147
Butyrate Promotes Induced Pluripotent Stem Cell Generation
Liang, G., Taranova, O., Xia, K., & Zhang, Y. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.142059 · Cited by 146
The Emerging Role of Insulin and Insulin-Like Growth Factor Signaling in Cancer Stem Cells
Malaguarnera, R., & Belfiore, A. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00010 · Cited by 147
p53 and stem cells: new developments and new concerns
Zhao, T., & Xu, Y. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2009.12.004 · Cited by 147
Chemical Control of Stem Cell Fate and Developmental Potential
Lyssiotis, C. A., Lairson, L. L., Boitano, A. E., Wurdak, H., Zhu, S., & Schultz, P. G. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201004284 · Cited by 143
Overcoming reprogramming resistance of Fanconi anemia cells
Müller, L., Milsom, M. D., Harris, C. E., Vyas, R., Brumme, K. M., Parmar, K., Moreau, L. A., Schambach, A., Park, I., London, W. B., et al. (2012) · Blood · doi:10.1182/blood-2012-02-408674 · Cited by 144
Cell state plasticity, stem cells, EMT, and the generation of intra-tumoral heterogeneity
Wahl, G. M., & Spike, B. T. (2017) · npj Breast Cancer · doi:10.1038/s41523-017-0012-z · Cited by 144
How mutations shape p53 interactions with the genome to promote tumorigenesis and drug resistance
Stiewe, T., & Haran, T. E. (2018) · Drug Resistance Updates · doi:10.1016/j.drup.2018.05.001 · Cited by 143
Regulation of Embryonic and Induced Pluripotency by Aurora Kinase-p53 Signaling
Lee, D., Su, J., Ang, Y.-S., Carvajal‐Vergara, X., Mulero‐Navarro, S., Pereira, C., Gingold, J. A., Wang, H.-L., Zhao, R., Sevilla, A., et al. (2012) · Cell stem cell · doi:10.1016/j.stem.2012.05.020 · Cited by 138
Takeuchi, S., Takahashi, A., Motoi, N., Yoshimoto, S., Tajima, T., Yamakoshi, K., Hirao, A., Yanagi, S., Fukami, K., Ishikawa, Y., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0801 · Cited by 136
Bao, L., He, L., Chen, J., Wu, Z., Liao, J., Rao, L., Ren, J., Li, H., Zhu, H., Qian, L., et al. (2011) · Cell Research · doi:10.1038/cr.2011.6 · Cited by 136
Induced Pluripotent Stem Cells: Reprogramming Platforms and Applications in Cell Replacement Therapy
Abbar, A. A., Ngai, S. C., Nograles, N., Alhaji, S. Y., & Abdullah, S. (2020) · BioResearch open access · doi:10.1089/biores.2019.0046 · Cited by 144
Prigione, A., & Adjaye, J. (2010) · The International Journal of Developmental Biology · doi:10.1387/ijdb.103198ap · Cited by 138
The functions of microRNAs in pluripotency and reprogramming
Leonardo, T. R., Schultheisz, H. L., Loring, J. F., & Laurent, L. C. (2012) · Nature Cell Biology · doi:10.1038/ncb2613 · Cited by 138
Cell cycle and p53 gate the direct conversion of human fibroblasts to dopaminergic neurons
Jiang, H., Xu, Z., Zhong, P., Ren, Y., Liang, G., Schilling, H. A., Hu, Z., Zhang, Y., Wang, X., Chen, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms10100 · Cited by 133
Concise Review: Control of Cell Fate Through Cell Cycle and Pluripotency Networks
Boward, B., Wu, T., & Dalton, S. (2016) · Stem Cells · doi:10.1002/stem.2345 · Cited by 147
Tanabe, K., Nakamura, M., Narita, M., Takahashi, K., & Yamanaka, S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310291110 · Cited by 131
Self-citationTakahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Sasaki, A., Yamamoto, M., Nakamura, M., Sutou, K., Osafune, K., & Yamanaka, S. (2014) · Nature Communications · doi:10.1038/ncomms4678 · Cited by 131
Self-citationRasmussen, M. A., Holst, B., Tümer, Z., Johnsen, M. G., Zhou, S., Stummann, T. C., Hyttel, P., & Clausen, C. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.07.006 · Cited by 134
Salmonella regulation of intestinal stem cells through the Wnt/β‐catenin pathway
Liu, X., Lu, R., Wu, S., & Sun, J. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.01.024 · Cited by 130
Pinho, A. V., Rooman, I., Reichert, M., De Medts, N., Bouwens, L., Rustgi, A. K., & Real, F. X. (2011) · Gut · doi:10.1136/gut.2010.225920 · Cited by 129
The p53 pathway in hematopoiesis: lessons from mouse models, implications for humans
Pant, V., Quintás-Cardama, A., & Lozano, G. (2012) · Blood · doi:10.1182/blood-2012-05-356014 · Cited by 129
microRNAs modulate iPS cell generation
Yang, C., Li, Z., & Rana, T. M. (2011) · RNA · doi:10.1261/rna.2664111 · Cited by 132
Eukaryotic DNA damage checkpoint activation in response to double-strand breaks
Finn, K., Lowndes, N. F., & Grenon, M. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0875-3 · Cited by 127
Induced Pluripotency and Oncogenic Transformation Are Related Processes
Riggs, J. W., Barrilleaux, B. L., Varlakhanova, N., Bush, K. M., Chan, V., & Knoepfler, P. S. (2012) · Stem Cells and Development · doi:10.1089/scd.2012.0375 · Cited by 127
The Fountain of Youth by Targeting Senescent Cells?
de Keizer, P. L. J. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.11.006 · Cited by 127
Zhang, Z., Chung, S., Xu, Z. Q., & Xu, Y. (2013) · Stem Cells · doi:10.1002/stem.1532 · Cited by 129
Induced pluripotent stem cells: developmental biology to regenerative medicine
Nelson, T. J., Martinez‐Fernandez, A., & Terzic, A. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.159 · Cited by 128
David, L., & Polo, J. M. (2014) · Stem Cell Research · doi:10.1016/j.scr.2014.03.007 · Cited by 126
Transient delivery of modified mRNA encoding TERT rapidly extends telomeres in human cells
Ramunas, J., Yakubov, E., Brady Jennifer, J., Corbel, S. Y., Holbrook, C., Brandt, M., Stein, J., Santiago, J. G., Cooke, J. P., & Blau, H. M. (2015) · The FASEB Journal · doi:10.1096/fj.14-259531 · Cited by 129
Regulation of Stem Cell Populations by microRNAs
Mathieu, J., & Ruohola‐Baker, H. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-6621-1_18 · Cited by 123
iPS cell technologies and cartilage regeneration
Tsumaki, N., Okada, M., & Yamashita, A. (2014) · Bone · doi:10.1016/j.bone.2014.07.011 · Cited by 125
p53: emerging roles in stem cells, development and beyond
Jain, A. K., & Barton, M. C. (2018) · Development · doi:10.1242/dev.158360 · Cited by 130
MicroRNA MiR-214 Regulates Ovarian Cancer Cell Stemness by Targeting p53/Nanog
Xu, C., Xu, M., Tan, L., Yang, H., Permuth‐Wey, J., Kruk, P. A., Wenham, R. M., Nicosia, S. V., Lancaster, J. M., Sellers, T. A., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.374611 · Cited by 120
RetractedWang, C., Rabadan Ros, R., Martinez-Redondo, P., Ma, Z., Shi, L., Xue, Y., Guillen-Guillen, I., Huang, L., Hishida, T., Liao, H.-K., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23353-z · Cited by 119
Reprogramming fibroblasts into induced pluripotent stem cells with Bmi1
Moon, J.-H., Heo, J. S., Kim, J. S., Jun, E. K., Lee, J. H., Kim, A., Kim, J., Whang, K. Y., Kang, Y., Yeo, S., et al. (2011) · Cell Research · doi:10.1038/cr.2011.107 · Cited by 120
Progress in the Reprogramming of Somatic Cells
Ma, T., Xie, M., Laurent, T., & Ding, S. (2013) · Circulation Research · doi:10.1161/circresaha.111.249235 · Cited by 120
Role of cellular senescence in inflammation and regeneration
Saito, Y., Yamamoto, S., & Chikenji, T. (2024) · Inflammation and Regeneration · doi:10.1186/s41232-024-00342-5 · Cited by 127
Direct conversion of human fibroblasts to induced serotonergic neurons
Xu, Z., Jiang, H., Zhong, P., Yan, Z., Chen, S., & Feng, J. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.101 · Cited by 116
p53: The barrier to cancer stem cell formation
Aloni-Grinstein, R., Shetzer, Y., Kaufman, T., & Rotter, V. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.02.011 · Cited by 117
Energy metabolism in the acquisition and maintenance of stemness
Folmes, C. D. L., & Terzic, A. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.02.010 · Cited by 119
Less understood issues: p21Cip1 in mitosis and its therapeutic potential
Kreis, N., Louwen, F., & Yuan, J. (2014) · Oncogene · doi:10.1038/onc.2014.133 · Cited by 116
Metabostemness: A New Cancer Hallmark
Menéndez, J. A., & Alarcón, T. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00262 · Cited by 116
Role of p53 in the Regulation of the Inflammatory Tumor Microenvironment and Tumor Suppression
Uehara, I., & Tanaka, N. (2018) · Cancers · doi:10.3390/cancers10070219 · Cited by 117
The role of TP53 in acute myeloid leukemia: Challenges and opportunities
Barbosa, K., Li, S., Adams, P. D., & Deshpande, A. J. (2019) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22796 · Cited by 118
Schmidt, R., & Plath, K. (2012) · Genome biology · doi:10.1186/gb-2012-13-10-251 · Cited by 120
Lineage conversion methodologies meet the reprogramming toolbox
Sancho-Martinez, I., Baek, S. H., & Belmonte, J. C. I. (2012) · Nature Cell Biology · doi:10.1038/ncb2567 · Cited by 115
Li, X., Li, G., Fu, J. L., Fu, Y.-W., Zhang, L., Chen, W., Arakaki, C., Zhang, J., Wen, W., Zhao, M., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky804 · Cited by 113
Apoptotic Caspases Regulate Induction of iPSCs from Human Fibroblasts
Li, F., He, Z., Shen, J., Huang, Q., Li, W., Liu, X., He, Y., Wolf, F., & Li, C. (2010) · Cell stem cell · doi:10.1016/j.stem.2010.09.003 · Cited by 115
Technological Overview of iPS Induction from Human Adult Somatic Cells
Bayart, É., & Cohen‐Haguenauer, O. (2013) · Current Gene Therapy · doi:10.2174/1566523211313020002 · Cited by 121
Regulation of cell differentiation by the DNA damage response
Sherman, M. H., Bassing, C. H., & Teitell, M. A. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.01.004 · Cited by 119
Cieślar‐Pobuda, A., Knoflach, V., Ringh, M. V., Stark, J., Likus, W., Siemianowicz, K., Ghavami, S., Hudecki, A., Green, J. L., & Łoś, M. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.04.017 · Cited by 117
Regulation of p53 is critical for vertebrate limb regeneration
Yun, M. H., Gates, P. B., & Brockes, J. P. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310519110 · Cited by 116
Induced Pluripotency and Epigenetic ReprogrammingPreprint
Hochedlinger, K., & Jaenisch, R. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a019448 · Cited by 120
Paramos-de-Carvalho, D., Jacinto, A., & Saúde, L. (2021) · eLife · doi:10.7554/elife.72449 · Cited by 111
A developmental framework for induced pluripotency
Takahashi, K., & Yamanaka, S. (2015) · Development · doi:10.1242/dev.114249 · Cited by 114
Self-citationIn vivo partial cellular reprogramming enhances liver plasticity and regeneration
Hishida, T., Yamamoto, M., Hishida-Nozaki, Y., Shao, C., Huang, L., Wang, C., Shojima, K., Xue, Y., Hang, Y., Shokhirev, M., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110730 · Cited by 116
Zhang, Q., Zeng, S. X., Zhang, Y., Zhang, Y.-W., Ding, D., Ye, Q.-Z., Meroueh, S. O., & Lu, H. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201100211 · Cited by 110
Emerging use of stem cells in regenerative medicine
Teo, A. K. K., & Vallier, L. (2010) · Biochemical Journal · doi:10.1042/bj20100102 · Cited by 111
Induced pluripotent stem cells and senescence: learning the biology to improve the technology
Banito, A., & Gil, J. (2010) · EMBO Reports · doi:10.1038/embor.2010.47 · Cited by 111
The p53 Pathway Controls SOX2-Mediated Reprogramming in the Adult Mouse Spinal Cord
Wang, L.-L., Su, Z., Tai, W., Zou, Y., Xu, X., & Zhang, C. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.038 · Cited by 107
The Intertwined Roles of Transcription and Repair Proteins
Fong, Y. W., Cattoglio, C., & Tjian, R. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.10.018 · Cited by 106
Aylon, Y., & Oren, M. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.10.002 · Cited by 106
Metadata
- Authors
- Hong, H., Takahashi, K., Ichisaka, T., Aoi, T., Kanagawa, O., Nakagawa, M., Okita, K., & Yamanaka, S.
- Affiliations
- Kyoto University (JP)
- RIKEN (JP)
- Gladstone Institutes (US)
- Corresponding author
- Yamanaka, Shinya
- Venue
- Nature
- Published
- 2009-08
- Volume
- 460
- Issue
- 7259
- Pages
- 1132-1135
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2917235
- OpenAlex
- W2081620485
- Cited by
- 1,301
- References
- 23
- Citations by year
- 2026: 13 · 2025: 16 · 2024: 25 · 2023: 29 · 2022: 44 · 2021: 51 · 2020: 41 · 2019: 56 · 2018: 63 · 2017: 59 · 2016: 78 · 2015: 88 · 2014: 116 · 2013: 117 · 2012: 168
- FWCI
- 67.71
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Kyoto University Research Information Repository (Kyoto University) (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute (U01HL100406)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- induced pluripotent stem cells, p53, p21, p53/p21 pathway, reprogramming efficiency, mouse embryonic fibroblasts, T cells, plasmid transfection, p53 target genes, tumorigenicity, Oct4, SOX2, KLF4, c-Myc
- MeSH terms
- Kruppel-Like Factor 4, Adult, Animals, Cell Differentiation, Embryo, Mammalian, Female, Fibroblasts, Humans, Male, Plasmids, T-Lymphocytes, Transfection, Tumor Suppressor Protein p53, Genes, myc, Oligonucleotide Array Sequence Analysis, Gene Silencing, Gene Expression Profiling, Pluripotent Stem Cells, Cyclin-Dependent Kinase Inhibitor p21, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
